We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Loss of IL-22 inhibits autoantibody formation in collagen-induced arthritis in mice.
- Authors
Corneth, Odilia B. J.; Reijmers, Rogier M.; Mus, Adriana M.C.; Asmawidjaja, Patrick S.; Hamburg, Jan Piet; Papazian, Natalie; Siegers, Jurre Y.; Mourcin, Frédéric; Amin, Rada; Tarte, Karin; Hendriks, Rudi W.; Cupedo, Tom; Lubberts, Erik
- Abstract
Interleukin 22 (IL-22) expression is associated with increased joint destruction and disease progression in rheumatoid arthritis (RA). Although IL-22 is considered a pro-inflammatory cytokine, its mechanism of action in RA remains incompletely understood. Here, we used the collagen-induced arthritis model in IL-22 deficient (IL-22−/−) mice to study the role of IL-22 in RA. In spite of normal disease incidence, disease severity is significantly diminished in IL-22−/− mice. Moreover, pathogenicity of Th17 cells and development and function of B cells are unaffected. In contrast, splenic plasma cells, as well as serum autoantibody titers, are reduced in the absence of IL-22. At the peak of disease, germinal centers (GCs) are severely reduced in the spleens of IL-22−/− mice, correlating with a decline in GC B-cell numbers. Within the GC, we identified IL-22R1 expressing follicular dendritic cell-like stromal cells. Human lymphoid stromal cells respond to IL-22 ex vivo by inducing transcription of CXCL12 and CXCL13. We therefore postulate IL-22 as an important enhancer of the GC reaction, maintaining chemokine levels for the persistence of GC reactions, essential for the production of autoantibody-secreting plasma cells. Blocking IL-22 might therefore prevent immune-complex deposition and destruction of joints in RA patients.
- Publication
European Journal of Immunology, 2016, Vol 46, Issue 6, p1404
- ISSN
0014-2980
- Publication type
Article
- DOI
10.1002/eji.201546241